Document Detail

Plasma vaporisation of the prostate: initial clinical results.
MedLine Citation:
PMID:  19482414     Owner:  NLM     Status:  In-Process    
BACKGROUND: Laser vaporisation of the prostate has had a considerable impact in recent years. In an attempt to achieve tissue vaporisation with bipolar high-frequency generators, plasma vaporisation was recently introduced.
OBJECTIVE: To provide the first clinical information on bipolar plasma vaporisation of the prostate for patients with lower urinary tract symptoms (LUTS) due to bladder outlet obstruction (BOO).
DESIGN, SETTING, AND PARTICIPANTS: Thirty patients were included in this prospective bicentre study.
INTERVENTION: All patients underwent bipolar plasma vaporisation with a novel electrode (Olympus Winter & Ibe GmbH, Hamburg, Germany).
MEASUREMENTS: International Prostate Symptom Score (IPSS), bother score, maximum flow rate (Q(max)), and postvoid residual were evaluated at baseline and at the time of discharge as well as at 1, 3, and 6 mo after the intervention.
RESULTS AND LIMITATIONS: Mean preoperative prostate volume was 59±32 ml (range: 30-170), and mean operating time was 61±26 min (range: 20-140). Besides one reoperation (conventional transurethral prostatectomy) due to persistent obstruction, no major complication occurred intra- or postoperatively and no blood transfusion was required. Catheterisation time averaged 41±35 h (range: 18-192). Transient mild to moderate dysuria was noted in four patients (13%). At 1, 3, and 6 mo, Q(max) increased from 6.6±2.7 ml/s preoperative to 17.3±4.7 ml/s (p<0.01), 18.5±4.6 ml/s (p<0.01), and 18.1±5.0 ml/s (p<0.01), respectively. The IPSS decreased from 20.8±3.6 to 10.4±3.5 (p<0.01), 8.2±2.9 (p<0.01), and 8.1±3.1 (p<0.01), respectively. These data represent a small nonrandomised study cohort with limited follow-up.
CONCLUSIONS: Our initial experience indicates that bipolar plasma vaporisation might be a safe and effective treatment option for patients with LUTS due to BOO. To define the potential role of this novel technique, randomised trials with longer follow-up are mandatory.
Oliver Reich; Boris Schlenker; Christian Gratzke; Derya Tilki; Malte Riecken; Christian Stief; Michael Seitz; Alexander Bachmann
Related Documents :
7538244 - Laparoscopic pelvic lymph node dissection, laparoscopically assisted seminal vesicle mo...
18825164 - The patients less than 50 years: is there a need to lower the psa cutoff point?
2483354 - Bladder outflow tract obstruction and urinary retention from benign prostatic hypertrop...
10432424 - Permanent radioactive seed implantation in the treatment of prostate cancer.
2407084 - Effect of pretreatment with aspirin versus aspirin plus dipyridamole on frequency and t...
1931394 - Comparison between sevoflurane and halothane for paediatric ambulatory anaesthesia.
Publication Detail:
Type:  Journal Article     Date:  2009-05-26
Journal Detail:
Title:  European urology     Volume:  57     ISSN:  1873-7560     ISO Abbreviation:  Eur. Urol.     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-10-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7512719     Medline TA:  Eur Urol     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  693-7     Citation Subset:  IM    
Copyright Information:
Copyright © 2009 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Department of Urology, University Hospital Munich Grosshadern, Ludwig Maximilians University, D 81377 Munich, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Comment In:
Eur Urol. 2010 Apr;57(4):697-8   [PMID:  19482413 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Assessment of the greenhouse effect impact of technologies used for energy recovery from municipal w...
Next Document:  Chlamydia trachomatis infection is related to poor semen quality in young prostatitis patients.